Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: SKI-606

Study type: Interventional

Funder types: Industry

Identifiers

NCT00499538

3160A4-1109

Details and patient eligibility

About

To evaluate the comparative bioavailability of 3 new tablet formulations of SKI-606 with a reference capsule and an oral solution in healthy subjects.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Criteria:

• Healthy male and female aged 18 to 50 years.
• Women of nonchildbearing potential (WONCBP).